AlphaFold predicted structure
DHCR24 · Q15392

Mean pLDDT
92.4/ 100
Very high
516 residues
Confidence breakdown
- Very high(≥ 90)75%
- Confident(70–90)24%
- Low(50–70)2%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
24-dehydrocholesterol reductase
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Arthrogryposis
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHydrocephalus
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+3 more panels — install the extension to see the full list inline on any page.
desmosterolosis
Non-immune hydrops fetalis
digestive system disorder
hereditary disease
schizophrenia
hepatocellular carcinoma
Alzheimer disease
breast cancer
urinary bladder cancer
urinary bladder carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Delta(24)-sterol reductase
Catalyzes the reduction of the delta-24 double bond of sterol intermediates during cholesterol biosynthesis (PubMed:11519011, PubMed:21671375, PubMed:22178193, PubMed:25637936). In addition to its cholesterol-synthesizing activity, can protect cells from oxidative stress by reducing caspase 3 activity during apoptosis induced by oxidative stress (PubMed:11007892, PubMed:22010141). Also protects against amyloid-beta peptide-induced apoptosis (PubMed:11007892)
DHCR24 · Q15392

Mean pLDDT
92.4/ 100
Very high
516 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0